SCHEMBL7684739

SCHEMBL7684739

COC(=O)c1ccc(N(C)S(C)(=O)=O)cc1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
L3MBTL1 Q9Y468 4/20 0.49
KDM4E B2RXH2 3/20 0.49
LMNA P02545 3/20 0.49
ALDH1A1 P00352 3/20 0.49
MEN1 O00255 3/20 0.49
HSD17B10 Q99714 2/20 0.49
TSHR P16473 2/20 0.49
MAPK1 P28482 1/20 0.43
USP2 O75604 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
RAB9A P51151 1/20 0.40
RECQL P46063 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA5A P35218 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7685275 0.87 KMT2A (0.43) KMT2AL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL7689754 0.83 L3MBTL1 (0.40) KMT2AL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL1110870 0.83 CA12 (0.43) KMT2AKDM4ELMNAALDH1A1MEN1
SCHEMBL7689767 0.82 KMT2A (0.52) KMT2AL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL1020557 0.82 KMT2A (0.52) KMT2AL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL22032894 0.79 KMT2A (0.52) KMT2AL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL7689758 0.78 PKM (0.53) KMT2AL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL7552070 0.77 KMT2A (0.64) KMT2AL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL7690635 0.76 CYP3A4 (0.40) KMT2AL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL7689461 0.75 KMT2A (0.62) KMT2AL3MBTL1KDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides MUSIL TIBOR (GB) 2002-04-18 US disclosed
US-6323155-B1 EXCELLENT LEVEL OF HERBICIDAL ACTIVITY TOGETHER WITH CROP TOLERANCE RHONE-POULENC AGRICULTURE LIMITED (GB) 2001-11-27 US disclosed
EP-0674629-B1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE POULENC AGRICULTURE (GB) 1998-07-08 EP disclosed
EP-0674629-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1995-10-04 EP disclosed
WO-1994014782-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides CBR3, CBR1, GLRA3 KMT2A 3499/4885L3MBTL1 2099/4885KDM4E 2527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.